T<\/span>he owners of the popular beer Corona have invested big into one of Canada\u2019s leading cannabis companies.<\/p>\n Constellation Brands<\/a>, whose portfolio also includes Svedka, Modelo and many other brands, recently invested $190 million in Canada\u2019s Canopy Growth corporation, according to the Wall Street Journal on Sunday. The money gets them a 10 percent stake in a company poised to do very well in Canada\u2019s forthcoming recreational marijuana market<\/a>.<\/p>\n In a statement announcing the deal, Canopy Growth noted that the strategic investment is \u201ca sign of confidence in Canopy Growth\u2019s reliable track record,\u201d referred to themselves as \u201cthe world\u2019s leading cannabis company\u201d and expressed excitement about bringing such a mainstream partner on board.<\/p>\n \u201cIn Constellation, we have a strategic ally that will join us as we lead the global cannabis sector into the future,\u201d said Bruce Linton, Canopy Growth\u2019s Chairman and CEO, in the statement. \u201cWe have also strengthened our balance sheet to fund the ambitious expansion efforts we\u2019ve announced leading into 2018 \u2013 a year that will see unprecedented growth in medical and adult-use opportunities.\u201d<\/p>\n From the prospective of many cannabis activists, such massive investment is only to be expected \u2014 and is likely to continue \u2014 as the industry grows and becomes more legitimized.<\/p>\n<\/blockquote>\n \u201cWith the growing success of the legalized marijuana market, it was inevitable that well funded corporations would begin to move in to capitalize on the industry,\u201d said Erik Altieri, NORML\u2019s executive director, in an email to Cannabis Now. \u201cWhile many large U.S.-based companies may hold off until they are more assured they won\u2019t face federal repercussions, plenty of them are certainly keeping a keen eye on the space.\u201d<\/p>\n Canopy, like their new partners, have many solid brands under their umbrella, and they call themselves the \u201cworld leading diversified cannabis brand.\u201d Their largest and most prominent subsidiary company is Tweed. Tweed <\/a>sells a lot of cannabis \u2014 including flower, oils and pills \u2014 but according to Canopy Growth, \u201cTweed doesn\u2019t just sell marijuana, it facilitates a conversation about a product we\u2019ve all heard about but haven\u2019t met intimately yet.\u201d They\u2019re also positioning for a share of the future global market share, really.<\/p>\n Second in their \u201ccore brands\u201d is Spectrum Cannabis, Canopy Growth\u2019s international medical brand. Spectrum has a more patient-centric focus than its sister company Tweed. Canopy has taken Spectrum\u2019s protocols developed in Canada and brought them around the world. While not as big a financial home-run as mailing pounds to the European recreational market, in a decade or two, this strategy is going to be sustainable and incredibly profitable. Developing best practices for patients across the board is where things are going with the actual separation of the existing medical<\/a> and adult use markets everywhere.<\/p>\n The third company, Bedrocan <\/a>Canada, is a medical producer in Canada that is revamping and evolving a lot of genetics<\/a> originally crafted in Holland by the old school Dutch masters.<\/p>\n In the cannabis space, Canopy had already been working with plenty of its biggest names already, including Snoop Dogg and DNA Genetics.<\/p>\n Constellation isn\u2019t the first beer company to dabble in the cannabis world. World Beer Cup medalist Thorn St Brewery and Jetty Extracts kicked off the terpene infused beer hype<\/a> last year. Leading craft brewery Lagunitas followed suit earlier this year<\/a> in a collaboration with Absolute Xtracts. For now, it appears that Constellation has no plans to partner with Canopy on any \u201cCorona & Cannabis\u201d products.<\/p>\n Charlie Alovisetti, senior associate and co-chair of the corporate department at the industry leading cannabis law practice Vicente Sederberg LLC<\/a>,<\/u> spoke highly of the portfolio Constellation is buying into to.<\/p>\n \u201cCanopy is among the most institutionally credible cannabis companies, as it trades on the TSX, the leading exchange in Canada, and it has a market capitalization of over two billion Canadian dollars,\u201d Alovisetti told Cannabis Now.<\/p>\n \u201cNo other direct cannabis company with the intent of joining the adult-use market comes close to this size,\u201d Alovisetti said.<\/p>\n<\/blockquote>\n According to Alovisetti, another contender for the most institutional cannabis company<\/a> is GW Pharmaceuticals, which also has a market capitalization of over $2 billion and trades on NASDAQ. \u201cBut GW Pharmaceuticals<\/a> does not sell flower or oil to patients; it is a pharmaceutical company that sells a treatment product for multiple sclerosis that is approved as a botanical drug, though not in the U.S. There has been no indication it has any interest in participating in the adult-use market,\u201d he said.<\/p>\n Alovisetti noted that there is currently no American equivalent to Canopy. He also isn\u2019t expecting any such mega-deals in the U.S. until federal laws change and the threat of prosecution is eliminated. \u201cLarge institutional companies are not comfortable entering a market when their only protection is an enforcement policy that could be changed quickly and easily,\u201d he said.<\/p>\n As a cannabis activist, NORML Executive Director Altieri suggested that the American cannabis industry should therefore prioritize, while they still can, moving to protect smaller businesses that are more likely to be pushed out of the industry when major funding starts pouring in.<\/p>\n \u201cThe pending, and likely inevitable, interest and involvement from major businesses in the legal marijuana industry is precisely why we must ensure to craft regulations that allow for ease of access for average citizens into the market and that promote small business owners and diversity over monopolistic corporate greed,\u201d Altieri said.<\/p>\n TELL US,<\/strong> do you think mainstream investment is beneficial to the cannabis industry?<\/p>\n The post Corona Owners Buy 10% of Major Canadian Pot Company<\/a> appeared first on Cannabis Now<\/a>.<\/p>\n
Bud and booze appear to be collaborating well north of the border. The owners of the popular beer Corona have invested big into one of Canada\u2019s leading cannabis companies. Constellation Brands, whose portfolio also includes Svedka, Modelo and many other brands, recently invested $190 million in Canada\u2019s Canopy Growth corporation,Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[34,50,505,80,170],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/20757"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=20757"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/20757\/revisions"}],"predecessor-version":[{"id":20758,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/20757\/revisions\/20758"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=20757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=20757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=20757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
\n
\nRead More: Corona Owners Buy 10% of Major Canadian Pot Company<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"